The rare complication of thrombotic thrombocytopenic purpura with AP has also been reported clinically, and it is speculated that the systemic inflammatory reaction may affect the activity of VWF, but there is no experimental evidence to confirm this [11,38]. This evidence concerns the gene VWF and thrombotic thrombocytopenic purpura.